Longdom Conferences hosts 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Tissue Engineering, Longdom Meetings is hosting its “2nd International Conference on Tissue Engineering, and Regenerative Medicine” scheduled for November 16-17, 2023 in Paris, France. The field of Stem Cells and Regenerative Medicine are one of the oldest scientific subjects, which is continuously evolving and have placed many landmarks in different research and development sectors. The Tissue Engineering 2023 extends immense pleasure in inviting you to join us at this conference which will be focusing on the theme “Latest Updates on Tissue Engineering”. We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on Stem Cells. This Stem Cells conference will focus on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.
Why join LONGDOM conferences?
Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore
Who will be the participants?
Academic Deans and Directors | Professors and project leads | Postdocs and research scholars | Young scientists and students | CEOs/ CFOs/ Chairs/ Vice-Chairs | Marketing/ business and development teams | Experts who are keen-sighted for collaboration | Product designers and resolution workers | Business sales & services professionals | Associations and society members | Funding organizations & fundraisers
Important Scientific Sessions
Track 1: Epigenetics Regulation of Mesenchymal Stem Cells: Mesenchymal stem cells (MSCs) have putative roles in maintaining adult tissue health, and the functional decline of MSCs has emerged as a crucial pathophysiological driver of various diseases. Epigenetic regulation is essential for establishing and preserving MSC homeostasis in vivo. Furthermore, growing evidence suggests that epigenetic dysregulation contributes to age- and disease-associated MSC alterations. Epigenetic marks in MSCs can be amplified through self-renewal divisions and transmitted to differentiated progeny, further perpetuating their role in tissue maintenance and pathogenesis. We review the epigenetic regulation of MSC homeostasis, emphasizing its contributions to organismal health and disease. Understanding these epigenetic mechanisms could hold promise as targets for MSC-mediated regenerative therapies.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 2: Genetic Engineering: Genetic engineering (also called genetic modification) is a process that uses laboratory-based technologies to alter the DNA makeup of an organism. This may involve changing a single base pair (A-T or C-G), deleting a region of DNA, or adding a new segment of DNA. For example, genetic engineering may involve adding a gene from one species to an organism from a different species to produce a desired trait. Used in research and industry, genetic engineering has been applied to the production of cancer therapies, brewing yeasts, genetically modified plants and livestock, and more.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 3: Molecular Biology: Molecular biology is the branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions. The study of chemical and physical structure of biological macromolecules is known as molecular biology.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 4: Cell and Gene Therapy: Cells are the essential building blocks of all living things, and genes are often found deep within cells. Genes are small sections of DNA that carry genetic information and directions for creating proteins, which help build and maintain the body. Every person has around 20,000 genes and two copies of every one of their genes one from each parent. Small variations in genes end in differences in people’s appearance and, potentially, health. Genetic diseases happen when a critical piece or whole section of DNA is substituted, deleted, or duplicated. These changes are called hereditary mutations. Some genetic severe diseases caused by genetic mutations are often passed to future generations.
1. AAV-based therapies
2. CAR-T cell therapies
3. CRISPR-based technologies
4. Gene regulation therapies
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 5: Stem Cell Theory of Aging: The stem cell theory of aging postulates that the aging process is the result of the inability of various types of stem cells to continue to replenish the tissues of an organism with functional differentiated cells capable of maintaining that tissue's (or organ's) original function. Damage and error accumulation in genetic material is always a problem for systems regardless of age. The number of stem cells in young people is very much higher than in older people and thus creates a better and more efficient replacement mechanism in the young contrary to the old. In other words, aging is not a matter of the increase in damage, but a matter of failure to replace it due to a decreased number of stem cells. Stem cells decrease in number and tend to lose the ability to differentiate into progenies or lymphoid lineages and myeloid lineages.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 6: Genomics, Proteomics, and Metabolomics: The most unexpected use of genomics has been its use as a counting device for DNA and RNA, furthering the study of molecular biology at a systems scale. Apart from counting RNA by converting them into DNA, genomics also has been instrumental in characterizing genomic protection by proteins that control which regions of the genome are active. Sensitive measurement of RNA has enabled catching RNA polymerases in the act of transcribing the genome. Research in our Department has pushed genomics beyond usual molecular biology applications by developing methods to sensitively measure enzyme activity in single cells. Our department is at the cutting edge in developing genomic technologies with applications ranging from structural epigenomics to how RNA modifications affect the aggressiveness of a cancer cell, to RNA stability, function, and structure.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 7: Cancer Cells and Cancer Stem Cells: Epithelial cancers are complex and exhibit inter-tumoral and intra-tumoral heterogeneity. Identifying specific cell types that initiate and sustain tumorigenesis is key to addressing tumor cell heterogeneity and other outstanding tumor biology questions. Cancer-initiating cell, or the cell-of-origin of cancer, is the normal cell that receives the first cancer-causing mutations. In other words, the cancer-initiating cell founds a future clinical tumor. Cancer stem cells (CSCs), on the other hand, are the cells that maintain tumor propagation
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 8: Tissue Engineering and Regenerative Medicine: Tissue Engineering evolved from the field of biomaterials development and refers to the practice of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. Artificial skin and cartilage are examples of engineered tissues that have been approved by the FDA; however, currently, they have limited use in human patients. Regenerative medicine is a broad field that includes tissue engineering but also incorporates research on self-healing – where the body uses its systems, sometimes with the help of foreign biological material to recreate cells and rebuild tissues and organs. The terms “tissue engineering” and “regenerative medicine” have become largely interchangeable, as the field hopes to focus on cures instead of treatments for complex, often chronic, diseases.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 9: Biomaterials and Bio Engineering: The field of bioengineering and biotechnology has gone through rapid developments over the past two decades owing to increased emphasis being placed on life sciences to improve the quality of life. These developments have eventually led to a better understanding of the mechanisms of failure of biomedical materials, drug delivery, and interactions of materials with the human tissue in the physiological environment to engineering aids in understanding the complex nature of DNA / RNA mapping in genomics. The present series covers the developments in the materials/ composites for bioengineering applications, interactions of these materials with human tissue and their possible effects, and developments in instrumental techniques and optics for biology and medicine. In general, the volumes will focus on application and the latest developments in engineering principles in life sciences to provide readers with the developments in various fields of bioengineering usually not covered in conventional texts.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Track 10:RNA Stem Cell Biology: Complex gene regulation systems ensure the maintenance of cellular identity during early development in mammals. Eukaryotic small RNAs have emerged as critical players in RNA interference (RNAi) by mediating gene silencing during embryonic stem cell self-renewal. Most of the proteins involved in the biogenesis of small RNAs are essential for proliferation and differentiation into the three germ layers of mouse embryonic stem cells. In the last decade, new functions for some RNAi proteins, independent of their roles in RNAi pathways, have been demonstrated in different biological systems. In parallel, new concepts in stem cell biology have emerged. Here, we review and integrate the current understanding of how RNAi proteins regulate stem cell identity with the new advances in the stem cell field and the recent non-canonical functions of the RNAi proteins. Finally, we propose a reevaluation of all RNAi mutant phenotypes, as non-canonical (small non-coding RNA independent) functions may contribute to the molecular mechanisms governing mouse embryonic stem cell commitment.
Related Conferences: Stem Cell Conferences, Tissue Engineering Conferences, Regenerative Medicine Conferences, Stem Cell Meetings, Stem Cell symposiums, Stem Cell Therapy Conference, Stem Cell Workshops, Top Stem Cell Conferences, Stem Cell Summit, Top Tissue Engineering Conferences
Market Analysis Report on Tissue Engineering
The global Tissue Engineering market size was computed at USD 9.9 billion in 2019 and is expected to witness a CAGR of 14.2% from 2020 to 2027. The potential of tissue engineering procedures in treating irreversible damage to tissues has boosted market growth. In addition, a rise in demand for regenerative medicine and tissue engineering procedures to treat damaged tissues further supplements this growth. Tissue engineering provides alternatives to surgical reconstruction, transplants, and other mechanical devices that are used to repair damaged tissues. The market for tissue engineering is also driven by a continuous increase in the need for effective regenerative treatments owing to a rise in the prevalence of diabetes, obesity, and other disorders due to lifestyle changes, an aging population, and growing trauma cases. Technological advancements in the field of 3D tissue engineering, such as the replacement of embryo cells with stem cells, organ-on-a-chip technology, and the use of 3D bioprinters that can efficiently design in vitro implants, are expected to enhance growth. In addition, an increase in government funding for medical and academic research activities would enhance the growth of the market for tissue engineering throughout the forecast period. For instance, the April 2019 published list for funding for various research, condition, and disease categories (RCDC) from the National Institutes of Health (NIH), (U.S.) indicates that funding for stem cell research and regenerative medicine was USD 1.8 and USD 1.0 billion respectively in 2018. The NIH estimates for funding in 2020 for these two areas correspond to USD 1.7 billion, and USD 915 million respectively.
Past Conference Reports
Report 1: Euro Stem Cells 2021
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Euro Stem Cells 2021 Conference successful. Global Meet on Stem Cell Research and Molecular Biology, hosted by the Longdom Conference was held during October 14-15, 2021 in Rome, Italy based on the theme “New Trends and Technologies in Stem Cell Research and Molecular Biology". The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1. Kazuko Tatsumura, Oriental Traditional Medicine of Japan, Japan
2. Khalid Shah, Harvard Medical School, USA
3. Gargi Maitra, Fortis Memorial Research Institute, India
4. Kelly Welton, La Quinta, USA
5. Jehad Zweiri, Marma Health Centre, India
Report 2: Stem Cells 2021
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Stem Cells 2021 Conference successful. International Conference on Stem Cell, Tissue Engineering Regenerative Medicine" to be held during September 29-30,2021 in Rome, Italy, hosted by the Longdom Conferences based on the theme “Advancement in Stem Cells Biology". The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1. Hongjun Wang, Medical University of South Carolina, USA
2. Kazuko Tatsumura, Oriental Traditional Medicine of Japan
3. Javad Sharifi-rad, India
4. Jehad Zweiri, University of Liverpool Medical School, USA
5. Barrington Brevitt, University of the West Indies, Jamaica
Report 3: Tissue Engineering 2022
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Tissue Engineering 2022 successful. International Conference on Tissue Engineering & Regenerative Medicine, hosted by the Longdom Conferences will be held during December 07-08, 2022 in Chicago, USA carrying the theme ‘Innovations and ideas towards Stem Cell Research”. The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1. Samar Mohammed Al-Saggaf, King Saud University, Saudi Arabia
2. Kevin Flynn, CaseBioscience, USA
3. Raja Tounsi, Gravity G- Gel, Tunisia
4. Hemant Dhamne, King’s College London, UK
5. Pradeep Mahajan, StemRx Bioscience Pvt Ltd, India
Report 4: Stem Cells 2022
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Stem Cells 2022 successful. 4th International Conference on Stem Cells, Tissue Engineering & Regenerative Medicine, which will be held on October 17 2022 carrying the theme ‘Innovations and ideas towards Stem Cell Research. The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1. Poonam Yadav, Sir Ganga Ram Hospital, India
2. Natalia Max, Zero Gravity Skin, USA
3. Azadeh Sepahvandi, University of South Carolina, USA
4. Denis G. Alekseev, Samara State Medical University, Russia
5. David Einy, ID Medical Devices, USA
Report 5: Stem Cells 2023
We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Stem Cells 2023 successful. 5th International Conference on Stem Cells, Tissue Engineering & Regenerative Medicine, which will be held during May 18-19, 2023 in Rome, Italy, hosted by the Longdom Conferences based on the theme “Current and Future Innovations in Stem Cell". The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1. Lucia Ceresa, Microbial Solutions, Charles River, Italy
2. Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech, Russia
3. Ashok Srivastava, Trans Atlantic Therapeutics LLC, USA
4. David Greene, R3 Stem Cell and US Lead Network, USA
5. Maurizio Serafini, Aldo Moro – Bari, Italy
We have received huge success in all those conferences & webinars with the help of our attendees, who are the true wheels behind the fruitful hosting. Now, as the situations are becoming normal and travel are mostly allowed, Longdom Conferences is proud to announce the " 2nd International Conference on Tissue Engineering and Regenerative Medicine" to be held November 16-17, 2023 in Paris, France.
For more details visit https://www.longdom.com/tissueengineering